跳至主要内容
临床试验/JPRN-UMIN000016916
JPRN-UMIN000016916已完成未知

Multicenter, retrospective, and observational study of afatinib treatment in patients with non-small cell lung cancer harboring EGFR mutation who previously treated with EGFR-TKI.

Central Japan Lung Study Group (CJLSG)0 个研究点目标入组 60 人开始时间: 2015年3月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 1) Patients with pathologically proven non-small cell lung cancer
  • 2) Patients with EGFR mutation (exon 19 deletion, exon 21 L858R, T790M, exon 20 insertion, and other minor mutations)
  • 3) Second line or later therapy of afatinib previously treated with EGFR-TKI

排除标准

  • 1) Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ

研究者

发起方
Central Japan Lung Study Group (CJLSG)

相似试验